Insights
MoCA Initiative and its Value Framework: An Opportunity to Improve Decision Making for Orphan Drugs in Europe?
18 September 2018
Orphan drugs inherently face a number of challenges in their development and value assessment. In this blog post, we describe the Mechanism of Coordinated Action (MoCA)…
NICE Recommendation Highlights Role of Social Value Judgements
9 August 2018
This blog post discusses the role of social value judgements in NICE technology appraisals, focusing on the recent appraisal of dinutuximab beta for high-risk neuroblastoma. The…
Alan Maynard – Alas No More
5 February 2018
Tony Culyer writes on the contribution to health economics of Alan Maynard, the pioneering health economist, who died on February 2nd 2018. If you wanted to…
The Long-term Sustainability of the NHS and Adult Social Care
13 April 2017
On 5th April 2017 the House of Lords Select Committee on the Long-term Sustainability of the NHS published their report titled “The Long-term Sustainability of the…
5 Things You Should Do with EQ-5D Data
29 January 2016
Professor Nancy Devlin outlines her top 5 recommendations for anyone collecting or reporting EQ-5D data. Written by Professor Nancy Devlin, Director of Research at OHE and…
Using Competition with Care: Comment on the Revised Regulations for the NHS
19 March 2013
OHE’s Jon Sussex has studied and written extensively on competition in the NHS. He was a member of the OHE Commission on Competition in the NHS…